132 related articles for article (PubMed ID: 25663449)
1. Polymorphisms in miRNA processing genes and their role in osteosarcoma risk.
Bilbao-Aldaiturriaga N; Gutierrez-Camino A; Martin-Guerrero I; Pombar-Gomez M; Zalacain-Diez M; Patiño-Garcia A; Lopez-Lopez E; Garcia-Orad A
Pediatr Blood Cancer; 2015 May; 62(5):766-9. PubMed ID: 25663449
[TBL] [Abstract][Full Text] [Related]
2. Genetic variants in miRNA processing genes and pre-miRNAs are associated with the risk of chronic lymphocytic leukemia.
Martin-Guerrero I; Gutierrez-Camino A; Lopez-Lopez E; Bilbao-Aldaiturriaga N; Pombar-Gomez M; Ardanaz M; Garcia-Orad A
PLoS One; 2015; 10(3):e0118905. PubMed ID: 25793711
[TBL] [Abstract][Full Text] [Related]
3. Variants in the 14q32 miRNA cluster are associated with osteosarcoma risk in the Spanish population.
Martin-Guerrero I; Bilbao-Aldaiturriaga N; Gutierrez-Camino A; Santos-Zorrozua B; Dolžan V; Patiño-Garcia A; Garcia-Orad A
Sci Rep; 2018 Oct; 8(1):15414. PubMed ID: 30337581
[TBL] [Abstract][Full Text] [Related]
4. Analysis of genes critical for growth regulation identifies Insulin-like Growth Factor 2 Receptor variations with possible functional significance as risk factors for osteosarcoma.
Savage SA; Woodson K; Walk E; Modi W; Liao J; Douglass C; Hoover RN; Chanock SJ;
Cancer Epidemiol Biomarkers Prev; 2007 Aug; 16(8):1667-74. PubMed ID: 17684144
[TBL] [Abstract][Full Text] [Related]
5. Noncoding RNA-related polymorphisms in pediatric acute lymphoblastic leukemia susceptibility.
Gutierrez-Camino A; Lopez-Lopez E; Martin-Guerrero I; Piñan MA; Garcia-Miguel P; Sanchez-Toledo J; Carbone Bañeres A; Uriz J; Navajas A; Garcia-Orad A
Pediatr Res; 2014 Jun; 75(6):767-73. PubMed ID: 24618566
[TBL] [Abstract][Full Text] [Related]
6. Upregulated expression of microRNA-214 is linked to tumor progression and adverse prognosis in pediatric osteosarcoma.
Wang Z; Cai H; Lin L; Tang M; Cai H
Pediatr Blood Cancer; 2014 Feb; 61(2):206-10. PubMed ID: 24038809
[TBL] [Abstract][Full Text] [Related]
7. CD86 + 1057G/A polymorphism and susceptibility to osteosarcoma.
Wang W; Song H; Liu J; Song B; Cao X
DNA Cell Biol; 2011 Nov; 30(11):925-9. PubMed ID: 21563968
[TBL] [Abstract][Full Text] [Related]
8. Single nucleotide polymorphism of hsa-miR-124a affects risk and prognosis of osteosarcoma.
Shi ZW; Wang JL; Zhao N; Guan Y; He W
Cancer Biomark; 2016 Jun; 17(2):249-57. PubMed ID: 27540978
[TBL] [Abstract][Full Text] [Related]
9. Single nucleotide polymorphisms within MicroRNAs, MicroRNA targets, and MicroRNA biogenesis genes and their impact on colorectal cancer survival.
Mullany LE; Herrick JS; Wolff RK; Slattery ML
Genes Chromosomes Cancer; 2017 Apr; 56(4):285-295. PubMed ID: 27859935
[TBL] [Abstract][Full Text] [Related]
10. Common genetic polymorphisms of microRNA biogenesis pathway genes and risk of breast cancer: a case-control study in Korea.
Sung H; Lee KM; Choi JY; Han S; Lee JY; Li L; Park SK; Yoo KY; Noh DY; Ahn SH; Kang D
Breast Cancer Res Treat; 2011 Dec; 130(3):939-51. PubMed ID: 21766210
[TBL] [Abstract][Full Text] [Related]
11. Endothelin-1 gene polymorphisms and risk of chemoresistant pediatric osteosarcoma.
Zhou Y; Liu B; Wang M; Ni J
Pediatr Blood Cancer; 2014 Apr; 61(4):612-7. PubMed ID: 24123836
[TBL] [Abstract][Full Text] [Related]
12. Genetic variations in interleukin-6 polymorphism and the association with susceptibility and overall survival of osteosarcoma.
Qi Y; Zhao C; Li H; Zhang B; Tada K; Abe H; Tada M
Tumour Biol; 2016 Jul; 37(7):9807-11. PubMed ID: 26810186
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms in lipid metabolism related miRNA binding sites and risk of metabolic syndrome.
Ye Q; Zhao X; Xu K; Li Q; Cheng J; Gao Y; Du J; Shi H; Zhou L
Gene; 2013 Oct; 528(2):132-8. PubMed ID: 23911300
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of common genetic variants in pre-microRNA in susceptibility and prognosis of esophageal cancer.
Umar M; Upadhyay R; Prakash G; Kumar S; Ghoshal UC; Mittal B
Mol Carcinog; 2013 Nov; 52 Suppl 1():E10-8. PubMed ID: 22692992
[TBL] [Abstract][Full Text] [Related]
15. Germ-line genetic variation of TP53 in osteosarcoma.
Savage SA; Burdett L; Troisi R; Douglass C; Hoover RN; Chanock SJ;
Pediatr Blood Cancer; 2007 Jul; 49(1):28-33. PubMed ID: 17096406
[TBL] [Abstract][Full Text] [Related]
16. Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.
Caronia D; Patiño-García A; Milne RL; Zalacain-Díez M; Pita G; Alonso MR; Moreno LT; Sierrasesumaga-Ariznabarreta L; Benítez J; González-Neira A
Pharmacogenomics J; 2009 Oct; 9(5):347-53. PubMed ID: 19434073
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA polymorphisms as markers of risk, prognosis and treatment response in hematological malignancies.
Dzikiewicz-Krawczyk A
Crit Rev Oncol Hematol; 2015 Jan; 93(1):1-17. PubMed ID: 25217091
[TBL] [Abstract][Full Text] [Related]
18. Role of variations within microRNA-binding sites in cancer.
Landi D; Gemignani F; Landi S
Mutagenesis; 2012 Mar; 27(2):205-10. PubMed ID: 22294768
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of genetic variants in microRNA-related genes and risk of bladder cancer.
Yang H; Dinney CP; Ye Y; Zhu Y; Grossman HB; Wu X
Cancer Res; 2008 Apr; 68(7):2530-7. PubMed ID: 18381463
[TBL] [Abstract][Full Text] [Related]
20. Association between H19 polymorphisms and osteosarcoma risk.
He TD; Xu D; Sui T; Zhu JK; Wei ZX; Wang YM
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3775-3780. PubMed ID: 28975992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
